The 2nd 2026 Mentorship Award, sponsored by @bridgebiopharma.bsky.social, supports US-based women physicians investigating early detection of ATTR-CM, with a focus on women.
Prepare your application to be part of this mentorship pair: womenasone.org/for-p...
#WomenAsOneAwards #CardioSky
Patients treated by female surgeons had better long-term outcomes - lower mortality & fewer complications. Within 90 days & 1 year, those treated by male surgeons were 25% more likely to die, readmit, or face complications.
Representation improves care.
jamanetwork.com/journals/jam...
#CardioSky
Text reads: Mentorship pairing #1: Al and equity in ATTR-CM. Applications open March 16th. Sponsored by Alnylam Pharmaceuticals.
The 1st 2026 Mentorship Award, sponsored by Alnylam Pharmaceuticals, will pair two women physicians to work on research focused on ATTR-CM, the role of AI & its impact on women.
Prepare your application to be part of this mentorship pair: womenasone.org/for-p...
#WomenAsOneAwards #CardioSky
Two Women As One leaders named cardiology leaders to watch in 2026 Dr. Roxana Mehran, Co-founder of Women As One Dr. Pamela Douglas, Women As One Board Member
We are proud to share that Dr Roxana Mehran and Dr Pamela Douglas have been named cardiology leaders to watch in 2026 by Becker’s Healthcare.
Their leadership in research, guidelines, and equity continues to shape the future of cardiovascular care.
www.beckersasc.com/c...
#CardioSky
For 3 years, women in cardiology have connected, learned, and driven change through RISE.
On #IWD2026, we celebrate those who have risen and are rising and invite you to join them at RISE @ ESC Congress 2026.
Register: womenasone.org/programs-eve...
#LetsRISE26 #ESCCongress @escardio.bsky.social
Figure: 'Inclusive FemTech: what makes it work'. Copyright: Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Despite comprising half the global population, women's health remaining a significant blind spot in modern medicine.
A new Viewpoint outlines FemTech, technology-enabled solutions to address the barriers & inequalities in care: spkl.io/63329AatGL
#IWD2026 #InternationalWomensDay
Advancing women's voices: women physicians leading the future of sex-specific cardiovascular science with new insights from amyloid cardiomyopathy March 28 6:30 - 8:30 PM CDT The Riverfront Hotel Rex Meeting Room Join us at ACC 2026
Join us and Pfizer at #ACC2026 for a focused discussion on sex-specific differences in amyloid cardiomyopathy and how evolving evidence is shaping diagnosis and care.
📅 March 28 | 6:30 to 8:30 PM CDT
📍 Riverfront Hotel
Space is limited. Register: womenasonepulse.org/...
#CardioSky
A Canadian study found that as the share of women physicians rose in a specialty, median payments grew less over time.
Small annual gaps compound into major lifetime income differences.
Representation alone is not equity.
jamanetwork.com/journals/jam...
#CardioSky
Yi-Hsin Hung, MD 2025 Mentee Award Winner Cardiology Fellow National Taiwan University Hospital Taiwan Two weeks ago, I had the incredible opportunity to be in Italy to meet my mentor, Dr. Carigi. Never could I have imagined such a moment - walking through the midnight streets of Italy, sharing gelato and stories about life, careers, and, of course, cardiac amyloidosis. Our project discussions flowed naturally, grounded in a shared vision and quiet determination. I'm deeply grateful to Dr. Carigi - not only for her expertise, but also for her warmth, encouragement, and belief in each of us. Being welcomed into that space of trust and generosity is something I'll carry with me! #WomenAsOneAwards
Mentorship can shape careers.
2025 Mentee Award winner Yi-Hsin Hung shared how time with her mentor, discussing science & leadership, strengthened her research vision and sense of belonging.
Be part of the 2026 Mentorship Awards: womenasone.org/for-p...
#WomenAsOneAwards #CardioSky
![Key Question
Dual antiplatelet therapy (DAPT) de-escalation improves outcomes after percutaneous coronary intervention compared to standard DAPT. What is the impact of sex on the safety and efficacy of these strategies?
Key Finding
In this pairwise and network meta-analysis with prespecified subgroup interaction, DAPT discontinuation reduced major adverse cardiovascular events compared to standard DAPT in females but not in males, while reducing major bleeding in males but not females. Conversely, no sex-related differences were found for P2Y13, inhibitor switch or dose reduction.
Take Home Message
Compared to standard DAPT, DAPT discontinuation may be particularly effective in females while P2Y12 Inhibitor switch or dose reduction may perform best in males.
[Graphic showing the best strategy for females and males to treat major bleeding and MACE, with a graph of the S-Node rankings of each treatment for major bleeding, MACE, all-cause deaths, NACE, CVD, MI, stroke, & any bleeding]](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:njigzo62iw5vv2fjdtwtin75/bafkreihfimmpymwvpvm24jgivmhr3qixu7syrfe5xxeqiuyekv5yykxuqe)
Key Question Dual antiplatelet therapy (DAPT) de-escalation improves outcomes after percutaneous coronary intervention compared to standard DAPT. What is the impact of sex on the safety and efficacy of these strategies? Key Finding In this pairwise and network meta-analysis with prespecified subgroup interaction, DAPT discontinuation reduced major adverse cardiovascular events compared to standard DAPT in females but not in males, while reducing major bleeding in males but not females. Conversely, no sex-related differences were found for P2Y13, inhibitor switch or dose reduction. Take Home Message Compared to standard DAPT, DAPT discontinuation may be particularly effective in females while P2Y12 Inhibitor switch or dose reduction may perform best in males. [Graphic showing the best strategy for females and males to treat major bleeding and MACE, with a graph of the S-Node rankings of each treatment for major bleeding, MACE, all-cause deaths, NACE, CVD, MI, stroke, & any bleeding]
Sex matters in DAPT de-escalation after PCI.
In 71,000+ patients, aspirin discontinuation reduced major CV events in women but not men, while lowering bleeding in men but not women. Precision care requires sex-specific evidence.
Read more: academic.oup.com/eur...
#CardioSky
Women As One Pfizer Join us at ACC 2026 March 28 6:30 - 8:30 PM CDT The Riverfront Hotel Rex Meeting Room
Sex-specific CV science is advancing, and we're ensuring women’s voices are involved.
Join Women As One & Pfizer at #ACC2026 for a focused discussion on sex-specific insights in amyloid cardiomyopathy and advancing equity in diagnosis and care.
Register: womenasonepulse.org/...
#CardioSky
Text reads: "2026 Mentorship Awards - Advancing women in cardiology"
Women belong at the forefront of CV research. The 2026 Mentorship Awards are here to help make that happen.
Structured, cross-institutional mentorship. High-impact research in ATTR-CM & lipid therapy in women.
Apply from March 16: womenasone.org/latest-news/...
#WomenAsOneAwards #CardioSky
"Study finds very high lipoprotein(a) levels correlated with increased 30-year risk of cardiovascular disease among healthy women - Women's Health Study"
🫀 1 blood test could help predict women's 30-year CV risk.
In nearly 28,000 healthy women followed for decades, elevated Lp(a) was linked to higher risk of MI, stroke, & CV death, even in those labeled “low risk.”
Lp(a) screening may reshape prevention.
jamanetwork.com/jour...
#CardioSky
Graphical abstract from the article.
Sex & age matter in acute coronary care.
In this study:
🔹Women 65+ had lower 30-day mortality with early invasive strategy (3.0% vs 5.1%)
🔹Younger women saw no benefit
🔹Men benefited at all ages
Women are not “small men.” Care must reflect biology.
www.sciencedirect.co...
#CardioSky
Join us for RISE @ ESC Congress 2026 and learn how mentorship, equity, and collaboration can shape the next generation of trial leaders and improve patient outcomes: womenasone.org/progr...
#LetsRISE2026 #ESCCongress
"By investing in the leadership development of women in cardiovascular medicine, we strengthen not only individual careers, but the entire field's capacity to address the complex challenges of modern healthcare." - Liesl Zühlke, Maria Rubini, Roxana Mehran RISE @ ESC Congress 2025 Program Directors
Insights from RISE @ ESC Congress 2025 Program Directors show how mentorship, collaboration, and equity improve trials, data, and patient outcomes.
Reflect on 2025: academic.oup.com/eur...
Then register for 2026 (link below)⬇️
#LetsRISE2026 #ESCCongress
MALE/FEMALE DIFFERENCES IN CABG OUTCOME Operative risk profile • Advanced age • Co-morbidities • Emergency surgery Operative technique • OPCAB / ONCAB • Graft material • Completeness of Revascularisation Disease Pattern • INOCA • HFpEF • Microvascular dysfunction
Women with CAD face less complete revascularization, higher short-term mortality after CABG, and lower referral to rehab. Disparities are multifactorial, and one-size-fits-all care falls short.
Gender-informed research and guidelines are essential.
www.oaepublish.com/a...
#cardiosky
If you're early in your career, mentoring someone who is, or considering how to support the next generation of women in research, this conversation with Drs Malissa Wood, Jessie Holtzman, Iulia Iatan, & Margaret Infeld is worth watching.
Watch the webcast: womenasone.org/resources/wo...
#CardioSky
Sex-specific differences in aortic stenosis matter. Women more often present with preserved EF & concentric remodeling, while men show more calcific disease, shaping progression & TAVR outcomes.
Inclusive trials & tailored care are essential.
Read more: www.sciencedirect.com/science/arti...
Advancing CV research takes more than innovation. It takes intention.
In our webcast, leading cardiologists share concrete steps trial leaders can take to strengthen clinical research, elevate women, & build inclusive leadership pathways.
Watch now: womenasone.org/resources/wo...
#CardioSky
A gender-medicine driven management approach should be considered for #acromegaly.
Women tend to have a longer diagnostic delay than men and a worse glycometabolic profile, but milder cardiac abnormalities despite higher CV mortality.
👉 buff.ly/QNEzbBp
#CardioSky
Events like this are important to really inspire women and to let them see what other women in the field are doing. Meeting with people from the House of Cardiology and leaders in cardiology who are women inspires us and motivates women like me and many others, especially the younger generation to get into cardiology. - Dr. Michele Friday, Director of Women's Heart Program, King's Daughters, USA - RISE @ ESC Congress 2025 Attendee
RISE @ ESC Congress is back for 2026 to bring women in cardiology together to connect, learn, grow, and inspire the next generation.
Join us and be part of a community committed to advancing women in cardiology.
Learn more: womenasone.org/progr...
#LetsRISE2026 #ESCCongress #CardioSky
📚#CAD affects millions in India, yet only 2,200 operational #Cardiac #CathLabs exist—far below demand. Expanding access, tackling gender inequities, & scaling hub-and-spoke models through smart policy reform can help bridge gaps. Read more⬇️
▶️ www.jscai.org/article/S277...
#CardioSky
🫀 Closing the gender gap in valvular heart disease starts with data.
The global VHD-W Registry spanning 32 countries is the first real-world initiative focused on sex disparities in diagnosis, referral, treatment & outcomes.
Evidence drives equity.
academic.oup.com/ehj...
#Cardiosky
Women As One is pleased to join Women’s HealthX as a strategic partner, bringing our global network, leadership development expertise & focus on research equity to a broader conversation.
Learn more: tinyurl.com/bddkb5xe
#CardioSky #WomensHealth
Sleep may be one of the most overlooked protectors of women’s heart health during menopause.
In nearly 3,000 US women, only 1 in 5 had optimal CV health, and sleep quality emerged as a key predictor of long-term outcomes.
Learn more: www.eurekalert.org/n...
#CardioSky
RISE Program Directors; Pamela Douglas, MD, (USA); Maria Rubini, MD, (Spain); Zainab Samad, MD, (Pakistan); Malissa J. Wood, MD, (USA)
Meet the 4 program directors shaping RISE @ ESC Congress 2026, bringing global perspectives to support women cardiologists worldwide.
Join us on August 27 for leadership development, connection, & growth.
Register now: womenasone.org/progr...
#LetsRISE2026 #ESCCongress #CardioSky
There's an urgent need to uncover the distinct mechanisms driving hypertension and its cardiovascular complications in females - an underexplored population. Closing this knowledge gap is essential for developing more effective, sex-specific treatments. - Dr. Chengxue Helena Qin, Monash University, Australia
A preclinical study identifies a key link between estrogen and ANXA1, a protein that protects against hypertension-related heart damage.
Lower ANXA1 led to greater CV damage in female models, reinforcing the need for sex-specific research and care.
www.monash.edu/news/...
#CardioSky
Text reads: "Women Who Lead. Malissa J. Wood, MD". Headshot of Malissa J. Wood, MD.
In our latest Women Who Lead, Women As One CMO Dr Malissa Wood speaks candidly about leadership, equity, and building sustainable pathways for women in cardiology.
Her perspective is a powerful reminder that change must be intentional.
Read the interview: womenasone.org/lates...
#CardioSky
"Stroke is a major cause of death and disability that may be preceded by distinct risk factors in women vs. men. Understanding earlier life, sex-specific stroke risk factors can help identify high-risk individuals who can be targeted for preventive intervention." - Dr. Abbi Lane, University of Michigan
Research shows pregnancy complications like preeclampsia or gestational diabetes can signal future CV risk.
We believe that supporting women physicians helps ensure these early warnings lead to tailored prevention & better long-term heart & brain health.
www.escardio.org/new...
#CardioSky
